<H1>Publications</H1>

<H2>2015</H2>

<UL>
<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/26312480">&#9758;</a>
Mather KJ, Pan Q, Knowler WC, Funahashi T, Bray GA, Arakaki R, Falkner B, Sharma K, Goldstein BJ (2015)
<B>Treatment-Induced Changes in Plasma Adiponectin Do Not Reduce Urinary Albumin Excretion in the Diabetes Prevention Program Cohort</B>.
<I>PLoS One</I>
10(8):e0136853     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/26224765">&#9758;</a>
Groop PH, Cooper ME, Perkovic V, Sharma K, Schernthaner G, Haneda M, Hocher B, Gordat M, Cescutti J, Woerle HJ, von Eynatten M (2015)
<B>Dipeptidyl peptidase-4 inhibition with linagliptin and effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: Rationale and design of the MARLINA-T2D trial</B>.
<I>Diab Vasc Dis Res</I>
12(6):455-62     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/26203118">&#9758;</a>
You YH, Quach T, Saito R, Pham J, Sharma K (2015)
<B>Metabolomics Reveals a Key Role for Fumarate in Mediating the Effects of NADPH Oxidase 4 in Diabetic Kidney Disease</B>.
<I>J Am Soc Nephrol</I>
(in press)     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/26136559">&#9758;</a>
Li H, Satriano J, Thomas JL, Miyamoto S, Sharma K, Pastor-Soler NM, Hallows KR, Singh P (2015)
<B>Interactions between HIF-1alpha and AMPK in the regulation of cellular hypoxia adaptation in chronic kidney disease</B>.
<I>Am J Physiol Renal Physiol</I>
309(5):F414-28     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/26052006">&#9758;</a>
Borgeson E, Johnson AM, Lee YS, Till A, Syed GH, Ali-Shah ST, Guiry PJ, Dalli J, Colas RA, Serhan CN, Sharma K, Godson C (2015)
<B>Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease</B>.
<I>Cell Metab</I>
22(1):125-37     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/25845900">&#9758;</a>
Abuyassin B, Sharma K, Ayas NT, Laher I (2015)
<B>Obstructive Sleep Apnea and Kidney Disease: A Potential Bidirectional Relationship?</B>
<I>J Clin Sleep Med</I>
11(8):915-24     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/25713188">&#9758;</a>
Sharma K (2015)
<B>Mitochondrial hormesis and diabetic complications</B>.
<I>Diabetes</I>
64(3):663-72     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/25701431">&#9758;</a>
Zhu K, Kakehi T, Matsumoto M, Iwata K, Ibi M, Ohshima Y, Zhang J, Liu J, Wen X, Taye A, Fan C, Katsuyama M, Sharma K, Yabe-Nishimura C (2015)
<B>NADPH oxidase NOX1 is involved in activation of protein kinase C and premature senescence in early stage diabetic kidney</B>.
<I>Free Radic Biol Med</I>
83:21-30     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/25470014">&#9758;</a>
Decleves AE, Sharma K (2015)
<B>Obesity and kidney disease: differential effects of obesity on adipose tissue and kidney inflammation and fibrosis</B>.
<I>Curr Opin Nephrol Hypertens</I>
24(1):28-36     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/25428125">&#9758;</a>
Zhao J, Miyamoto S, You YH, Sharma K (2015)
<B>AMP-activated protein kinase (AMPK) activation inhibits nuclear translocation of Smad4 in mesangial cells and diabetic kidneys</B>.
<I>Am J Physiol Renal Physiol</I>
308(10):F1167-77     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/25419705">&#9758;</a>
Kang HM, Ahn SH, Choi P, Ko YA, Han SH, Chinga F, Park AS, Tao J, Sharma K, Pullman J, Bottinger EP, Goldberg IJ, Susztak K (2015)
<B>Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development</B>.
<I>Nat Med</I>
21(1):37-46     
</LI>

</UL>
<H2>2014</H2>
<UL>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/25503637">&#9758;</a>
Decleves AE, Sharma K, Satriano J (2014)
<B>Beneficial Effects of AMP-Activated Protein Kinase Agonists in Kidney Ischemia-Reperfusion: Autophagy and Cellular Stress Markers</B>.
<I>Nephron Exp Nephrol</I>
128:98â€“110
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/25366041">&#9758;</a>
Sharma K, Natarajan L (2014)
<B>Diabetes: statins for microvascular complications-all but the kidney</B>.
<I>Nat Rev Nephrol</I>
10(12):680-1     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/24676635">&#9758;</a>
Borsting E, Patel SV, Decleves AE, Lee SJ, Rahman QM, Akira S, Satriano J, Sharma K, Vallon V, Cunard R (2014)
<B>Tribbles homolog 3 attenuates mammalian target of rapamycin complex-2 signaling and inflammation in the diabetic kidney</B>.
<I>J Am Soc Nephrol</I>
25(9):2067-78     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/24676633">&#9758;</a>
Sharma K (2014)
<B>Tell-tale signs of perturbed podocytes</B>.
<I>J Am Soc Nephrol</I>
25(7):1367-9     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/24662433">&#9758;</a>
Decleves AE, Sharma K (2014)
<B>Novel targets of antifibrotic and anti-inflammatory treatment in CKD</B>.
<I>Nat Rev Nephrol</I>
10(5):257-67     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/24417947">&#9758;</a>
Sweiss N, Sharma K (2014)
<B>Adiponectin effects on the kidney</B>.
<I>Best Pract Res Clin Endocrinol Metab</I>
28(1):71-9     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/24304883">&#9758;</a>
Decleves AE, Zolkipli Z, Satriano J, Wang L, Nakayama T, Rogac M, Le TP, Nortier JL, Farquhar MG, Naviaux RK, Sharma K (2014)
<B>Regulation of lipid accumulation by AMP-activated kinase [corrected] in high fat diet-induced kidney injury</B>.
<I>Kidney Int</I>
85(3):611-23     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/25401040">&#9758;</a>
Sharma K (2014)
<B>Obesity, oxidative stress, and fibrosis in chronic kidney disease</B>.
<I>Kidney Int Suppl (2011)</I>
4(1):113-117     
</LI>

</UL>
<H2>2013</H2>
<UL>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/24179009">&#9758;</a>
Miyamoto S, Sharma K (2013)
<B>Adipokines protecting CKD</B>.
<I>Nephrol Dial Transplant</I>
28 Suppl 4:iv15-22     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/23901047">&#9758;</a>
Satriano J, Sharma K (2013)
<B>Autophagy and metabolic changes in obesity-related chronic kidney disease</B>.
<I>Nephrol Dial Transplant</I>
28 Suppl 4:iv29-36     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/23825068">&#9758;</a>
Satriano J, Sharma K, Blantz RC, Deng A (2013)
<B>Induction of AMPK activity corrects early pathophysiological alterations in the subtotal nephrectomy model of chronic kidney disease</B>.
<I>Am J Physiol Renal Physiol</I>
305(5):F727-33     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/23751262">&#9758;</a>
Borgeson E, Sharma K (2013)
<B>Obesity, immunomodulation and chronic kidney disease</B>.
<I>Curr Opin Pharmacol</I>
13(4):618-24     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/23389458">&#9758;</a>
You YH, Okada S, Ly S, Jandeleit-Dahm K, Barit D, Namikoshi T, Sharma K (2013)
<B>Role of Nox2 in diabetic kidney disease</B>.
<I>Am J Physiol Renal Physiol</I>
304(7):F840-8     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/23152292">&#9758;</a>
Vallon V, Rose M, Gerasimova M, Satriano J, Platt KA, Koepsell H, Cunard R, Sharma K, Thomson SC, Rieg T (2013)
<B>Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus</B>.
<I>Am J Physiol Renal Physiol</I>
304(2):F156-67     
</LI>

</UL>
<H2>2012</H2>
<UL>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/22835457">&#9758;</a>
Diamond-Stanic MK, You YH, Sharma K (2012)
<B>Sugar, sex, and TGF-beta in diabetic nephropathy</B>.
<I>Semin Nephrol</I>
32(3):261-8     
</LI>

</UL>
<H2>2011</H2>
<UL>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/21921143">&#9758;</a>
Decleves AE, Mathew AV, Cunard R, Sharma K (2011)
<B>AMPK mediates the initiation of kidney disease induced by a high-fat diet</B>.
<I>J Am Soc Nephrol</I>
22(10):1846-55     
</LI>



<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/21659774">&#9758;</a>
Mathew A, Cunard R, Sharma K (2011)
<B>Antifibrotic treatment and other new strategies for improving renal outcomes</B>.
<I>Contrib Nephrol</I>
170:217-27
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/21543418">&#9758;</a>
Sanchez AP, Zhao J, You Y, Decleves AE, Diamond-Stanic M, Sharma K (2011)
<B>Role of the USF1 transcription factor in diabetic kidney disease</B>.
<I>Am J Physiol Renal Physiol</I>
301(2):F271-9     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/21511828">&#9758;</a>
Sharma K, Ix JH, Mathew AV, Cho M, Pflueger A, Dunn SR, Francos B, Sharma S, Falkner B, McGowan TA, Donohue M, Ramachandrarao S, Xu R, Fervenza FC, Kopp JB (2011)
<B>Pirfenidone for diabetic nephropathy</B>.
<I>J Am Soc Nephrol</I>
22(6):1144-51     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/21067508">&#9758;</a>
Mathew AV, Okada S, Sharma K (2011)
<B>Obesity related kidney disease</B>.
<I>Curr Diabetes Rev</I>
7(1):41-9     
</LI>

</UL>
<H2>2010</H2>
<UL>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/20729505">&#9758;</a>
Gayen JR, Zhang K, RamachandraRao SP, Mahata M, Chen Y, Kim HS, Naviaux RK, Sharma K, Mahata SK, O'Connor DT (2010)
<B>Role of reactive oxygen species in hyperadrenergic hypertension: biochemical, physiological, and pharmacological evidence from targeted ablation of the chromogranin a (Chga) gene</B>.
<I>Circ Cardiovasc Genet</I>
3(5):414-25     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/20539226">&#9758;</a>
Vallon V, Sharma K (2010)
<B>Sodium-glucose transport: role in diabetes mellitus and potential clinical implications</B>.
<I>Curr Opin Nephrol Hypertens</I>
19(5):425-31     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/20505038">&#9758;</a>
Satriano J, Mansoury H, Deng A, Sharma K, Vallon V, Blantz RC, Thomson SC (2010)
<B>Transition of kidney tubule cells to a senescent phenotype in early experimental diabetes</B>.
<I>Am J Physiol Cell Physiol</I>
299(2):C374-80     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/20440278">&#9758;</a>
Decleves AE, Sharma K (2010)
<B>New pharmacological treatments for improving renal outcomes in diabetes</B>.
<I>Nat Rev Nephrol</I>
6(6):371-80     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/20150538">&#9758;</a>
Ix JH, Sharma K (2010)
<B>Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK</B>.
<I>J Am Soc Nephrol</I>
21(3):406-12     
</LI>

</UL>
<H2>2009</H2>
<UL>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/19578007">&#9758;</a>
RamachandraRao SP, Zhu Y, Ravasi T, McGowan TA, Toh I, Dunn SR, Okada S, Shaw MA, Sharma K (2009)
<B>Pirfenidone is renoprotective in diabetic kidney disease</B>.
<I>J Am Soc Nephrol</I>
20(8):1765-75     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/19404275">&#9758;</a>
Sharma K (2009)
<B>The link between obesity and albuminuria: adiponectin and podocyte dysfunction</B>.
<I>Kidney Int</I>
76(2):145-8     
</LI>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/19397838">&#9758;</a>
Sanchez AP, Sharma K (2009)
<B>Transcription factors in the pathogenesis of diabetic nephropathy</B>.
<I>Expert Rev Mol Med</I>
11:e13     
</LI>

</UL>
<H2>2008</H2>
<UL>

<LI>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18431508">&#9758;</a>
Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L, Falkner B, Goldstein BJ (2008)
<B>Adiponectin regulates albuminuria and podocyte function in mice</B>.
<I>J Clin Invest</I>
118(5):1645-56     
</LI>

</UL>



